Becton, Dickinson and Company

BDX

Healthcare Medical Instruments & Supplies

Revenue
−10.5%
EPS
+48.5%
Free cash flow
−31.6%
Total debt
−23.8%

Quarter to September 2026, against a year earlier

211.88 1.67 −0.78%
Market cap
$58.2B
P/E
51.1×
Fwd P/E
25.0×
Dividend yield
1.87%
F-score
6/9
ROIC
3.94%
Net debt / EBITDA
2.8×
Dividend safety
51/100

Becton, Dickinson and Company (BDX) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Becton, Dickinson and Company (BDX) trades at a P/E ratio of 51.1×. Over the past ten years it has ranged from 0.0× (June 2018) to 423× (October 2018); the current reading is higher than 77% of that period. That is above the Medical Instruments & Supplies industry median of 30.8× and above the Healthcare sector median of 24.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 43.1× 68.01%
FY2025 25.7× (20.91%)
FY2024 32.4× (21.55%)
FY2023 41.3× 37.23%
FY2022 30.1× 8.02%
FY2021 27.9× (57.95%)
FY2020 66.3× 32.45%
FY2019 50.1× (88.16%)
FY2018 423× 1,211.16%
FY2017 32.3× 7.42%

Quarterly newest first

Period P/E ratio Change
Sep 2026 43.1× (5.45%)
Jun 2026 45.6× 14.51%
Mar 2026 39.8× 57.10%
Dec 2025 25.3× (1.22%)
43 more quarters

Against its own ten years

Low 0.0× High 423×
Ten-year median 35.5×
Current reading's percentile 74

P/E ratio against peers

Company P/E ratio
BAX Baxter International Inc. compare n/m
COO The Cooper Companies, Inc. compare 21.3×
RMD ResMed Inc. compare 21.4×
WST West Pharmaceutical Services, Inc. compare 44.5×
MDLN Medline Inc. compare 48.4×
BDX Becton, Dickinson and Company 51.1×
ISRG Intuitive Surgical, Inc. compare 54.2×
ALC Alcon compare 57.1×
SOLV Solventum Corporation compare 102×
Medical Instruments & Supplies industry median 30.8×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BDX